Author Correction: Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial
Amy D. Klion
Nature Medicine, Published online: 05 May 2026; doi:10.1038/s41591-026-04425-3 Author Correction: Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial